Format

Send to

Choose Destination
Curr Oncol Rep. 2004 May;6(3):177-83.

Hepatocellular carcinoma: epidemic and treatment.

Author information

1
Division of Gastrointestinal Oncology, University of California at San Francisco School of Medicine, UCSF Medical Center, 1600 Divisadero, Box 1705, San Francisco, CA 94115-1610, USA.

Abstract

Hepatocellular carcinoma remains a worldwide epidemic. Survival rates are poor; however, oncologists are able to offer regional therapies to those patients who present with early disease. Prevention through vaccination remains a mainstay of this epidemic. New staging systems that incorporate important information about tumor characteristics and liver disease improve our ability to prognosticate and treat these patients.

PMID:
15066228
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center